• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于 ELISA 的桥接测定法作为 ADCC 的替代指标的开发。

Development of an ELISA based bridging assay as a surrogate measure of ADCC.

机构信息

Analytical Development and Quality Control, Genentech, Inc., 1 DNA Way, South San Francisco, CA 94080, USA.

出版信息

J Immunol Methods. 2012 Nov 30;385(1-2):45-50. doi: 10.1016/j.jim.2012.08.004. Epub 2012 Aug 14.

DOI:10.1016/j.jim.2012.08.004
PMID:22914441
Abstract

Antibody dependent cell-mediated cytotoxicity (ADCC) is an important mechanism of action (MoA) for many monoclonal antibody (mAb) therapeutics. As such, quantitative measurement of ADCC activity is key to drug development. Traditional cell lysis based ADCC assays using PBMCs or NK cell lines can be challenging to develop and implement for routine testing. To provide an alternative to the cell lysis based ADCC assay, a non-cell based measure of ADCC activity was developed to determine the ADCC activity of an anti-CD20 mAb, which measures the ability of the mAb to bind to CD20 antigen and FcγRIIIa, simultaneously. The bridging of CD20 and FcγRIIIa is an essential interaction for the initiation of ADCC activity. This ADCC bridging method is simple, offers the ease of use of a standard ELISA, and shows reproducible dose-response curves in the concentration range of 50-1000 ng/mL. With interassay variability of 7-10% and recovery of 89-115%, the assay demonstrates acceptable precision and accuracy. The assay is able to detect degradative changes in anti-CD20 mAb samples subjected to light and acid exposure, suggesting that it is suitable for use as a stability-indicating method. The assay is also sensitive to mAb fucose levels. A linear relationship between the ADCC bridging assay and the cell lysis ADCC assay was demonstrated, strongly suggesting that the ADCC bridging assay can be used as a surrogate measure of ADCC.

摘要

抗体依赖的细胞介导的细胞毒性(ADCC)是许多单克隆抗体(mAb)治疗药物的重要作用机制(MoA)。因此,定量测量 ADCC 活性是药物开发的关键。使用 PBMC 或 NK 细胞系的传统基于细胞裂解的 ADCC 测定法在开发和实施常规测试方面可能具有挑战性。为了提供基于细胞裂解的 ADCC 测定法的替代方法,开发了一种非基于细胞的 ADCC 活性测量方法,以确定抗 CD20 mAb 的 ADCC 活性,该方法测量 mAb 与 CD20 抗原和 FcγRIIIa 结合的能力,同时。CD20 和 FcγRIIIa 的桥接是启动 ADCC 活性的必要相互作用。这种 ADCC 桥接方法简单,提供了标准 ELISA 的易用性,并在 50-1000ng/mL 的浓度范围内显示出可重复的剂量反应曲线。具有 7-10%的批间变异性和 89-115%的回收率,该测定法表现出可接受的精密度和准确性。该测定法能够检测到经受光照和酸暴露的抗 CD20 mAb 样品中的降解变化,表明它适合用作稳定性指示方法。该测定法也对 mAb 岩藻糖水平敏感。ADCC 桥接测定法和细胞裂解 ADCC 测定法之间显示出线性关系,强烈表明 ADCC 桥接测定法可用作 ADCC 的替代测量方法。

相似文献

1
Development of an ELISA based bridging assay as a surrogate measure of ADCC.基于 ELISA 的桥接测定法作为 ADCC 的替代指标的开发。
J Immunol Methods. 2012 Nov 30;385(1-2):45-50. doi: 10.1016/j.jim.2012.08.004. Epub 2012 Aug 14.
2
Enhancement of the antibody-dependent cellular cytotoxicity of low-fucose IgG1 Is independent of FcgammaRIIIa functional polymorphism.低岩藻糖基化IgG1抗体依赖性细胞毒性的增强与FcγRIIIa功能多态性无关。
Clin Cancer Res. 2004 Sep 15;10(18 Pt 1):6248-55. doi: 10.1158/1078-0432.CCR-04-0850.
3
Combined Fc-protein- and Fc-glyco-engineering of scFv-Fc fusion proteins synergistically enhances CD16a binding but does not further enhance NK-cell mediated ADCC.Fc 蛋白和 Fc 糖基工程联合修饰 scFv-Fc 融合蛋白可协同增强 CD16a 结合,但不能进一步增强 NK 细胞介导的 ADCC。
J Immunol Methods. 2011 Oct 28;373(1-2):67-78. doi: 10.1016/j.jim.2011.08.003. Epub 2011 Aug 9.
4
Development of a quantitative, cell-line based assay to measure ADCC activity mediated by therapeutic antibodies.开发一种定量的、基于细胞系的测定法,以测量治疗性抗体介导的 ADCC 活性。
Mol Immunol. 2011 Jul;48(12-13):1512-7. doi: 10.1016/j.molimm.2011.04.010. Epub 2011 May 14.
5
Enhanced natural killer cell binding and activation by low-fucose IgG1 antibody results in potent antibody-dependent cellular cytotoxicity induction at lower antigen density.低岩藻糖基化IgG1抗体增强自然杀伤细胞的结合与激活,可在较低抗原密度下有效诱导抗体依赖性细胞毒性。
Clin Cancer Res. 2005 Mar 15;11(6):2327-36. doi: 10.1158/1078-0432.CCR-04-2263.
6
Expression of human FcgammaRIIIa as a GPI-linked molecule on CHO cells to enable measurement of human IgG binding.在 CHO 细胞上表达人 FcγRIIIa 作为 GPI 连接分子,以实现人 IgG 结合的测量。
J Immunol Methods. 2010 Mar 31;354(1-2):20-33. doi: 10.1016/j.jim.2010.01.011. Epub 2010 Feb 4.
7
Expression of GnTIII in a recombinant anti-CD20 CHO production cell line: Expression of antibodies with altered glycoforms leads to an increase in ADCC through higher affinity for FC gamma RIII.GnTIII在重组抗CD20 CHO生产细胞系中的表达:具有改变糖型的抗体的表达通过对FcγRIII的更高亲和力导致ADCC增加。
Biotechnol Bioeng. 2001 Aug 20;74(4):288-94.
8
Development of a robust reporter-based ADCC assay with frozen, thaw-and-use cells to measure Fc effector function of therapeutic antibodies.开发一种基于报告基因的稳健的抗体依赖性细胞介导的细胞毒性(ADCC)检测方法,使用冻融即用型细胞来测量治疗性抗体的Fc效应子功能。
J Immunol Methods. 2014 Dec 1;414:69-81. doi: 10.1016/j.jim.2014.07.010. Epub 2014 Jul 31.
9
Nonfucosylated therapeutic IgG1 antibody can evade the inhibitory effect of serum immunoglobulin G on antibody-dependent cellular cytotoxicity through its high binding to FcgammaRIIIa.非岩藻糖基化治疗性IgG1抗体可通过与FcγRIIIa的高亲和力结合,规避血清免疫球蛋白G对抗体依赖性细胞毒性的抑制作用。
Clin Cancer Res. 2006 May 1;12(9):2879-87. doi: 10.1158/1078-0432.CCR-05-2619.
10
Identification of IgG(1) variants with increased affinity to FcγRIIIa and unaltered affinity to FcγRI and FcRn: comparison of soluble receptor-based and cell-based binding assays.鉴定对 FcγRIIIa 亲和力增加而对 FcγRI 和 FcRn 亲和力不变的 IgG(1)变体:基于可溶性受体和基于细胞的结合测定法的比较。
J Immunol Methods. 2011 Feb 28;365(1-2):132-41. doi: 10.1016/j.jim.2010.12.014. Epub 2010 Dec 23.

引用本文的文献

1
The Role of Fc Receptors on the Effectiveness of Therapeutic Monoclonal Antibodies.Fc 受体在治疗性单克隆抗体疗效中的作用。
Int J Mol Sci. 2021 Aug 19;22(16):8947. doi: 10.3390/ijms22168947.
2
Development of a cell-based assay measuring the activation of FcγRIIa for the characterization of therapeutic monoclonal antibodies.开发一种基于细胞的检测方法,用于测量FcγRIIa的激活,以表征治疗性单克隆抗体。
PLoS One. 2014 Apr 21;9(4):e95787. doi: 10.1371/journal.pone.0095787. eCollection 2014.